In addition, miR-132 regulated tau expression and phosphorylation, and thus contributed to tauopathy in AD by regulating MeCP2 levels, suggesting a vicious cycle of tau-miR-132-MeCP2-tau abnormalities in AD (Xie et al., 2019). The gene discussed is MAPT; the disease is tauopathy.